Core Viewpoint - Robbins LLP has initiated a class action lawsuit on behalf of investors who acquired Reckitt Benckiser Group PLC American Depository Shares (ADSs) between January 13, 2021, and July 28, 2024, alleging that the company misled investors regarding the safety of its Enfamil baby formula [1][2]. Allegations - The lawsuit claims that Reckitt failed to inform investors and consumers about the increased risk of necrotizing enterocolitis (NEC) in preterm infants consuming its cow's milk-based formula, Enfamil, and the potential negative impact on sales and legal exposure [2]. - A jury in Illinois awarded $60 million in a case against Mead Johnson, finding negligence in failing to warn about the risks associated with cow's milk-based formula, which led to a significant drop in Reckitt's ADS price [3]. - Following a similar case in Missouri, where Abbott Laboratories was found liable for NEC-related damages, Reckitt's ADS price also experienced a notable decline [4]. Class Action Participation - Shareholders interested in serving as lead plaintiffs in the class action must file a motion by August 4, 2025, but participation is not required to be eligible for recovery [5].

Core Viewpoint - A class action lawsuit has been filed against Ibotta, Inc. for allegedly misleading investors regarding the risks associated with its contracts, particularly with Kroger, which could be terminated at will [1][2][3] Group 1: Allegations and Legal Proceedings - Robbins LLP is investigating claims that Ibotta did not adequately disclose the at-will nature of its contract with Kroger, potentially misleading investors [2] - The complaint highlights that Ibotta's 2Q 2024 10-Q did not mention Kroger as a client, despite its inclusion in the Registration Statement, raising concerns about transparency [3] - Shareholders interested in participating in the class action must file their papers by June 16, 2025, to serve as lead plaintiff [4] Group 2: Company Performance - Since its IPO, Ibotta's stock has significantly declined, trading well below the initial offering price of $88.00 per share [3]